Enhancing patient knowledge and behaviour through digital health communication: a systematic review and random-effects meta-analysis of mobile, web-based, social media, telehealth, and AI-enabled interventions Authors: Asma Alshanqiti, Hadel Alghabban, Amal Mohammed Q. Surrati, Sara Ibrahim, Wejdan Owaydhah Published: 2026 ABSTRACT BackgroundDigital technologies are increasingly used to support health communication, yet their impact on knowledge, behaviour, and health literacy outcomes remains unclear. Previous reviews have often conflated improvements in knowledge with digital health literacy, without carefully distinguishing skills from outcomes.ObjectiveTo systematically review and synthesize evidence on the effectiveness of digital health communication interventions—including mobile apps, web platforms, social media, telehealth/video tools, and emerging AI-enabled approaches—on knowledge, behaviour, clinical, and empowerment outcomes, while distinguishing these outcomes from digital health literacy when directly measured.MethodsWe searched PubMed, Embase, Scopus, CINAHL, Web of Science, and Cochrane Library (January 2015 to January 2026). Eligible studies included randomized and non-randomized trials evaluating digital interventions designed to improve health knowledge, literacy, behaviours, or related outcomes. Only English-language, peer-reviewed studies were included; grey literature, conference abstracts, dissertations, preprints, and unpublished studies were not systematically searched. Random-effects meta-analysis was performed where outcomes were comparable, with subgroup and sensitivity analyses. For subgroup analyses, overlapping multi-component interventions were assigned once using a prespecified dominant patient-facing modality rule based on the main user interface and delivery channel; AI-enabled status was applied only when AI materially informed personalization or decision support. Certainty of evidence was graded using GRADE.ResultsThirty studies met inclusion criteria, and 12 contributed to at least one pooled meta-analysis. Continuous knowledge/literacy outcomes showed a small, statistically non-significant pooled effect (SMD 0.25; 95% CI: −0.04 to 0.54) with substantial heterogeneity. Dichotomous behavioural outcomes showed a statistically significant improvement (OR 3.57; 95% CI: 1.60 to 7.97), but this estimate was based on only two studies and should be interpreted cautiously. Mobile and web-based interventions provided the most frequent directionally favourable evidence, whereas AI-enabled, social media, and telehealth/video modalities were sparsely represented. Clinical and empowerment outcomes were too heterogeneous for pooling and showed mixed findings. GRADE certainty was low for knowledge/literacy, clinical, and empowerment outcomes and moderate only for selected behavioural outcomes.ConclusionDigital health communication interventions may support patient knowledge and selected health behaviours; however, the strength of evidence remains limited by high heterogeneity, small numbers of pooled studies, overlapping intervention features, risk of bias, variable outcome measures, and exclusion of grey literature and non-English studies. Stronger conclusions about effectiveness, particularly for AI-enabled, social media, and telehealth/video approaches, require adequately powered trials using standardized literacy, behavioural, clinical, and empowerment outcomes.Systematic review registrationPROSPERO registration number: CRD42024625595. Introduction The transformation in the creation, dissemination, and use of health information is driven by digital technologies, including wearable devices, social media, telehealth platforms, mobile applications, and conversational agents (1, 2). This enables personalized support for behaviour change, interactive education, and targeted messaging (3, 4). More recently, advances in artificial intelligence (AI), such as machine learning, natural language processing, and adaptive decision-support systems, have expanded the potential for digital technologies to deliver scalable, customized, and timely interventions (5). With issues of accessibility, usability, and governance being adequately addressed, digital health is increasingly recognized by global health organizations as a critical enabler of equitable and effective health systems (6–8). There are three related but distinct concepts: health literacy, digital health literacy, and health communication (1, 9, 10). Health literacy is a set of cognitive and social competencies that enable people to access, understand, appraise, and apply health information to make informed decisions (10, 11). Digital health literacy (DHL) extends these competencies to digital environments, including searching for, evaluating, and applying online health information or interacting with digital platforms (12, 13). Health communication is distinguished from those concepts in that the central aim is to describe and deliver strategies for informing and influencing health decisions (14, 15). AI in health communication includes technologies designed to tailor health information, provide automated counselling via chatbots or virtual assistants, and use predictive analytics to support engagement and self-management (16, 17). While recent years have seen rapid expansion in the integration of AI, early systems, such as MYCIN developed in the 1970s, indicate this has been a long-term development rather than a recent phenomenon (18). Most digital health interventions report at least one of the following: increased screening uptake, improved treatment adherence, physical activity, or psychological well-being (19–21). Many studies also report increase in knowledge or patient empowerment (22). However, few studies have directly measured DHL with a validated tool, which precludes conclusions on whether any improvement in health outcomes has been mediated by improved literacy skills, or by other mechanisms, including better tailoring of messages, ease of access, etc. (23–25). This gap complicates interpretation but also underscores the importance of framing current evidence as an evaluation of digital communication tools and their effects on knowledge, behaviour, and health outcomes, with implications for digital health literacy where measured. The aim of this systematic review and meta-analysis is therefore to evaluate the effectiveness of digital health communication interventions—including mobile, web-based, social media, telehealth/video, and AI-enabled tools—on knowledge, behaviour, clinical, and empowerment outcomes, while distinguishing these effects from digital health literacy unless DHL was directly measured. Specifically, the review (i) synthesizes evidence on the effects of digital interventions on knowledge, behaviour change, and health outcomes; (ii) quantifies pooled effects where comparable outcomes are available; and (iii) identifies gaps in measurement, equity, and implementation to guide future research and policy. Operationally, this review treated the digital platform or communication channel as the intervention mechanism and treated knowledge, behaviour, clinical outcomes, empowerment, and directly measured DHL as separate outcome domains. Improvements in disease-specific knowledge, adherence, or engagement were not interpreted as evidence of improved digital health literacy unless a validated DHL instrument was used. This distinction guided eligibility decisions, outcome grouping, subgroup interpretation, and the cautious interpretation of pooled estimates. Methods Protocol and reporting This systematic review and meta-analysis followed the PRISMA 2020 guidelines to ensure rigor and transparency (26). The study protocol was prospectively registered with PROSPERO (CRD42024625595). Any deviations from the protocol (e.g., outcome grouping, analytical refinements) are reported in the Supplementary Materials. Conceptual scope and definitions Because prior literature often conflates improvements in knowledge or behaviour with improvements in (digital) health literacy, we clarified definitions at the outset:Health literacy: the cognitive and social skills that enable individuals to access, understand, appraise, and apply health information in decision-making.Digital health literacy (DHL): the application of these competencies in digital environments (e.g., evaluating online information, using apps, or interacting with digital platforms).Health communication (focus of this review): digital communication strategies—including apps, web portals, telehealth, social media, and AI-enabled tools—designed to inform, motivate, or support health-related decisions. Health literacy: the cognitive and social skills that enable individuals to access, understand, appraise, and apply health information in decision-making. Health literacy: the cognitive and social skills that enable individuals to access, understand, appraise, and apply health information in decision-making. Digital health literacy (DHL): the application of these competencies in digital environments (e.g., evaluating online information, using apps, or interacting with digital platforms). Digital health literacy (DHL): the application of these competencies in digital environments (e.g., evaluating online information, using apps, or interacting with digital platforms). Health communication (focus of this review): digital communication strategies—including apps, web portals, telehealth, social media, and AI-enabled tools—designed to inform, motivate, or support health-related decisions. Health communication (focus of this review): digital communication strategies—including apps, web portals, telehealth, social media, and AI-enabled tools—designed to inform, motivate, or support health-related decisions. We therefore evaluate outcomes of digital health communication interventions, and when DHL was directly measured using validated instruments (e.g., eHEALS, DHLI), it was treated as a distinct outcome and potential mediator rather than assumed proxy. Eligibility criteria (PICOS) Population: Children, adolescents, and adults from any setting. Studies focusing on underserved groups (e.g., low-SES, rural, older adults) were eligible.Interventions: Digitally mediated, patient-facing health communication (apps, web-based tools, telehealth, chatbots, AI-based decision support, or social media campaigns). Multi-component programs were included if the digital communication element was central or separately evaluated.Comparators: Standard care, non-digital interventions, waitlist/attention control, alternative digital interventions, or pre-post without a comparator if otherwise eligible.Outcomes: At least one primary outcome domain—knowledge, behaviour, clinical/health outcomes, or empowerment. Studies measuring only satisfaction/usability without health outcomes were excluded. Secondary outcomes included engagement, adoption, satisfaction, and patient–provider communication.Study designs: Only interventional studies evaluating patient-facing digital health communication tools with measurable effects on knowledge, behaviour, clinical, or empowerment outcomes were eligible for inclusion. Validation studies, trial protocols, and secondary analyses without assessment of intervention effects were excluded from quantitative synthesis. Population: Children, adolescents, and adults from any setting. Studies focusing on underserved groups (e.g., low-SES, rural, older adults) were eligible. Population: Children, adolescents, and adults from any setting. Studies focusing on underserved groups (e.g., low-SES, rural, older adults) were eligible. Interventions: Digitally mediated, patient-facing health communication (apps, web-based tools, telehealth, chatbots, AI-based decision support, or social media campaigns). Multi-component programs were included if the digital communication element was central or separately evaluated. Interventions: Digitally mediated, patient-facing health communication (apps, web-based tools, telehealth, chatbots, AI-based decision support, or social media campaigns). Multi-component programs were included if the digital communication element was central or separately evaluated. Comparators: Standard care, non-digital interventions, waitlist/attention control, alternative digital interventions, or pre-post without a comparator if otherwise eligible. Comparators: Standard care, non-digital interventions, waitlist/attention control, alternative digital interventions, or pre-post without a comparator if otherwise eligible. Outcomes: At least one primary outcome domain—knowledge, behaviour, clinical/health outcomes, or empowerment. Studies measuring only satisfaction/usability without health outcomes were excluded. Secondary outcomes included engagement, adoption, satisfaction, and patient–provider communication. Outcomes: At least one primary outcome domain—knowledge, behaviour, clinical/health outcomes, or empowerment. Studies measuring only satisfaction/usability without health outcomes were excluded. Secondary outcomes included engagement, adoption, satisfaction, and patient–provider communication. Study designs: Only interventional studies evaluating patient-facing digital health communication tools with measurable effects on knowledge, behaviour, clinical, or empowerment outcomes were eligible for inclusion. Validation studies, trial protocols, and secondary analyses without assessment of intervention effects were excluded from quantitative synthesis. Study designs: Only interventional studies evaluating patient-facing digital health communication tools with measurable effects on knowledge, behaviour, clinical, or empowerment outcomes were eligible for inclusion. Validation studies, trial protocols, and secondary analyses without assessment of intervention effects were excluded from quantitative synthesis. Report characteristics: Peer-reviewed studies published in English between January 2015 and January 2026. Conference abstracts, dissertations, preprints, and other unpublished or grey-literature sources were not included. Outcome definition Outcomes were defined a priori and analysed according to a hierarchical framework reflecting increasing proximity to clinical impact. The hierarchy was applied consistently across study selection, data extraction, narrative synthesis, and meta-analysis:Digital Health Literacy (primary outcome): Measured exclusively using validated instruments assessing competencies related to accessing, understanding, appraising, and applying digital health information (e.g., eHEALS, DHLI, HLQ digital domains). Proxy measures and unvalidated scales were not classified as digital health literacy outcomes.Knowledge outcomes: Disease-specific or health-related knowledge assessed through validated questionnaires, standardized tests, or clearly defined structured assessments. Knowledge outcomes were analysed separately from digital health literacy and were not treated as equivalent constructs.Behavioural outcomes: Health-related behaviours were categorized as either objective (e.g., registry-verified screening uptake, device-recorded physical activity) or self-reported (e.g., questionnaires, activity logs). Where both were available, objective measures were prioritised.Clinical outcomes: Patient-level health outcomes, including clinical indicators (e.g., biometrics, symptom scores), healthcare utilisation, or quality-of-life measures assessed using validated instruments. These outcomes were synthesised narratively due to limited homogeneity. Digital Health Literacy (primary outcome): Measured exclusively using validated instruments assessing competencies related to accessing, understanding, appraising, and applying digital health information (e.g., eHEALS, DHLI, HLQ digital domains). Proxy measures and unvalidated scales were not classified as digital health literacy outcomes. Digital Health Literacy (primary outcome): Measured exclusively using validated instruments assessing competencies related to accessing, understanding, appraising, and applying digital health information (e.g., eHEALS, DHLI, HLQ digital domains). Proxy measures and unvalidated scales were not classified as digital health literacy outcomes. Knowledge outcomes: Disease-specific or health-related knowledge assessed through validated questionnaires, standardized tests, or clearly defined structured assessments. Knowledge outcomes were analysed separately from digital health literacy and were not treated as equivalent constructs. Knowledge outcomes: Disease-specific or health-related knowledge assessed through validated questionnaires, standardized tests, or clearly defined structured assessments. Knowledge outcomes were analysed separately from digital health literacy and were not treated as equivalent constructs. Behavioural outcomes: Health-related behaviours were categorized as either objective (e.g., registry-verified screening uptake, device-recorded physical activity) or self-reported (e.g., questionnaires, activity logs). Where both were available, objective measures were prioritised. Behavioural outcomes: Health-related behaviours were categorized as either objective (e.g., registry-verified screening uptake, device-recorded physical activity) or self-reported (e.g., questionnaires, activity logs). Where both were available, objective measures were prioritised. Clinical outcomes: Patient-level health outcomes, including clinical indicators (e.g., biometrics, symptom scores), healthcare utilisation, or quality-of-life measures assessed using validated instruments. These outcomes were synthesised narratively due to limited homogeneity. Clinical outcomes: Patient-level health outcomes, including clinical indicators (e.g., biometrics, symptom scores), healthcare utilisation, or quality-of-life measures assessed using validated instruments. These outcomes were synthesised narratively due to limited homogeneity. This hierarchy was used to prevent conceptual overlap, ensure analytical consistency, and avoid conflation of literacy, knowledge, behavioural, and clinical effects. Information sources and search strategy We searched PubMed/MEDLINE, Embase, Scopus, Web of Science, CINAHL, and Cochrane Library (January 2015–January 2026). Search terms combined subject headings and keywords for “digital health,” “health communication,” “artificial intelligence,” “behaviour change,” and “health outcomes.” Full strategies are available in Supplementary Table S1. Reference lists of included articles and relevant reviews were hand-searched to identify additional studies. Grey literature sources, conference abstracts, dissertations, preprints, and unpublished studies were not systematically searched. Study selection Two reviewers independently screened titles/abstracts and then full texts against eligibility criteria. Disagreements were resolved by discussion or a third reviewer. Cohen’s κ was calculated at both stages. Full-text exclusion reasons were recorded and mapped to PRISMA categories (e.g., no eligible outcomes, insufficient data, no patient-facing communication, wrong comparator, non-interventional design, non-English). The PRISMA 2020 flow diagram (Figure 1) summarizes identification, screening, eligibility, and inclusion. Study flow diagram using the preferred reporting items for systematic reviews and meta-analyses. Data extraction Using a piloted template, two reviewers independently extracted relevant data from each included study. This process encompassed study metadata such as publication year, country, study design, setting, and sample size. Participant characteristics were also recorded, including age, sex, socioeconomic status (SES), and health status. Intervention details were documented thoroughly, covering the type of technology used, presence of AI features, duration of the intervention, mode of delivery, and any theoretical framework underpinning the approach. Information on comparators was noted, along with outcomes measured using validated scales where applicable, the tools used for measurement, and the timing of follow-up assessments. Effect sizes or data suitable for calculating them were extracted, and funding sources or conflicts of interest were recorded. In cases where multiple reports described the same study, data were consolidated to avoid duplication. When information was incomplete, study authors were contacted twice for clarification. Any disagreements between reviewers were resolved through consensus. Risk of bias and quality assessment Risk of bias was assessed using appropriate tools based on study design. For randomized controlled trials (RCTs) and cluster RCTs, the Cochrane Risk of Bias 2 (RoB 2) tool was applied (27). Non-randomized studies were evaluated using the ROBINS-I tool, while pre–post studies without a control group were assessed using either the NIH Before–After Tool or the JBI checklist (28, 29). Two reviewers conducted the assessments independently, with any disagreements resolved through adjudication by a third reviewer. Domain-level and overall judgments were summarized in tables and figures. This multi-tool approach was chosen to address concerns about applying RCT-specific tools to non-randomized designs, ensuring a more accurate and context-sensitive evaluation of study quality. Outcomes and measurement hierarchy Each study’s outcomes were mapped to prespecified domains. If multiple outcomes existed within one domain, we prioritized: (i) validated scale > (ii) composite domain-aligned score > (iii) single-item proxy. When both change-from-baseline and post-test values were available, adjusted post-test or change scores were preferred. Data synthesis and effect measures The meta-analysis for Knowledge and Behaviour outcomes was conducted using Review Manager, developed by the Cochrane Collaboration. REVMAN is widely recognized for performing systematic reviews and meta-analyses, particularly in health and social sciences research. Extracted data from eligible studies were entered into the software under appropriate outcome categories (Knowledge and Behaviour). For continuous outcomes, mean values, standard deviations, and total sample sizes were entered, and pooled effect sizes were calculated using either Mean Difference (MD) or Standardized Mean Difference (SMD), depending on measurement scale consistency across studies. If outcomes were dichotomous, risk ratios (RR) or odds ratios (OR) were computed. A random-effects model was applied where heterogeneity was anticipated due to variations in study populations, instruments, and intervention characteristics. Statistical heterogeneity was assessed using the Chi-square (χ2) test and quantified with the I2 statistic, where values of 25, 50, and 75% represent low, moderate, and high heterogeneity, respectively. Forest plots were generated to visually display individual study effects and pooled estimates with 95% confidence intervals. Publication bias was explored using funnel plots to assess symmetry. Sensitivity analysis was performed where necessary to evaluate the stability of pooled estimates. The overall effect was interpreted using the Z-test with a significance level set at p < 0.05. Because clinical and methodological heterogeneity was anticipated, pooled estimates were interpreted as summary signals rather than as evidence of a single common intervention effect. Where I2 was high, interpretation emphasized the direction, precision, and consistency of effects, prediction intervals, and sensitivity analyses rather than statistical significance alone. When fewer than three clinically comparable studies contributed data, pooled estimates were retained only as exploratory summaries and were not used for definitive inference. Subgroup, sensitivity, and bias analyses Planned subgroup analyses included: (i) AI-enabled vs. conventional interventions; (ii) adolescents vs. older adults vs. underserved populations; (iii) delivery modality (apps, web, social media, telehealth); (iv) study design (RCT vs. non-RCT); and (v) baseline literacy (where available). Because several interventions combined overlapping features (e.g., app + AI personalization or messaging + video), studies were allowed to contribute to more than one narrative category, but for subgroup meta-analyses each study was assigned once to the dominant patient-facing communication modality using a prespecified rule: mobile app or web platform by the primary user interface; social media only when the social platform itself was the main delivery channel; telehealth/video when synchronous or video-led communication was central; and AI-enabled status only when AI materially informed personalization, tailoring, or decision support rather than merely supporting background workflow. Certainty of evidence Certainty for each outcome domain was rated using GRADE, considering risk of bias, inconsistency, indirectness, imprecision, and publication bias. Results are summarized in “summary of findings” tables. Ethics The review synthesized published studies and did not involve new data collection from human subjects; therefore, ethics approval was not required. Results Study selection Study selection followed the PRISMA 2020 guidelines to ensure transparency and methodological rigor (Figure 1). A total of 1,105 records were identified through database searching, including PubMed (n = 247), EMBASE (n = 190), Cochrane Central (n = 212), CINAHL (n = 190), Scopus (n = 180), Web of Science (n = 76), and other sources (n = 10). After removal of 342 duplicates, 763 records underwent title and abstract screening, of which 719 were excluded for reasons such as irrelevance (n = 548), study protocols (n = 27), irrelevant outcomes (n = 69), insufficient data (n = 62), and caregiver-facing tools (n = 13). Full texts of 44 reports were sought, with 11 not retrievable. Of the 33 reports assessed for eligibility, 3 were excluded due to insufficient data, resulting in 30 studies meeting the inclusion criteria for the systematic review, of which 12 were eligible for quantitative synthesis (meta-analysis). Characteristics of included studies The 30 included studies represent a wide geographical distribution, covering high-, middle-, and low-income settings across the USA, Europe, Asia, Africa, and Oceania, and involved diverse populations including older adults, adolescents, pregnant women, parents of young children, chronic disease cohorts, cancer survivors, and underserved communities. Health areas included preventive screening, reproductive and maternal health, diabetes and other chronic disease self-management, mental health, cardiovascular care, oral health, and school-based literacy/education. Across studies, digital health communication interventions varied markedly in format and technological complexity. Common modalities included mobile applications such as a medication-inquiry app for CKD patients (30), the mPATH-CRC screening support app (31), parental literacy app KhunLook (32), and the AI-personalized Flo menstrual health app (33), as well as web-based platforms such as weight-management programs (34), interactive physical activity tools (35), the application-based Levidex programme (36), and multimedia mental-health literacy modules (37). Several studies implemented video-based or telecommunication-delivered education, including WhatsApp animated storytelling for maternal health (38) and iPad-based digital animations for AF ablation patients (39). A smaller group evaluated social-media-based interventions, such as Instagram-delivered lifestyle content (40), or game-based digital literacy tools for schoolchildren (41). A few studies incorporated AI-supported or algorithm-guided components, such as Flo’s personalization engine (33); however, the genomic return-of-results platform (42) was a protocol/design study rather than an outcomes evaluation. The targeted populations reflected varying equity considerations. Several studies intentionally focused on underserved or low-SES groups, including older adults with limited digital access (43), safety-net clinic patients with low health literacy (31), pregnant women in LMIC settings (38, 44), rural hypertension cohorts (45), and underrepresented racial groups in genomics (42). Other studies targeted youth and young adults through digital literacy interventions (46), mental-health video modules (47), or lifestyle programs (48). Intervention goals and outcome measures also varied considerably. Many studies primarily assessed knowledge or literacy outcomes, for example maternal knowledge (38, 49), parental health literacy (32), menstrual health literacy (33), nutrition literacy (50), or general/mental-health literacy (37, 46, 51, 52). Others focused on behavioural outcomes, such as CRC screening uptake (31), physical activity (35), lifestyle behaviours in adolescents (48), or oral hygiene adherence (53). Several studies further reported clinical or psychosocial outcomes, including distress reduction (54), insomnia severity (55), AF-related quality of life (39), or medication adherence in oncology populations (56). Study designs were predominantly randomized controlled trials including cluster and pilot RCTs, although non-randomized controlled studies (43, 44, 57), quasi-experimental designs (45), and validation or secondary analyses (54, 58) were also represented. Follow-up duration ranged from immediate post-intervention to 12-month outcomes, with substantial variability depending on intervention complexity and target population. Overall, the included studies collectively reflect a heterogeneous but methodologically informative evidence base evaluating digital health communication interventions across diverse populations, technologies, and outcome domains. Many studies reported measurable improvements in knowledge, literacy, engagement, or health behaviours; however, differences in intervention content, platform design, comparator type, follow-up duration, and outcome instruments limit direct comparability. The evidence base was also uneven across modalities: mobile and web-based interventions were well represented, whereas social media, telehealth/video, and AI-enabled approaches were comparatively underrepresented (see Table 1). Table 1Characteristics of included studies.Author (Year), countrySetting & population (n)Equity focusIntervention (type; duration; delivery; AI)ComparatorPrimary outcome(s) + instrumentSecondary outcomes + instrumentFollow-upEffect (direction & magnitude)Study designRisk of bias (overall)Meta-analysis inclusion (domain)NotesDiamantidis et al. (2015), USA (30)CKD outpatients; adults (n = 20)Some low-SESMobile medication-inquiry app; 3 mo; app/SMS; AI: noneStandard careMedication safety/errors (audit)Usability & satisfaction (questionnaires)3 monthsHigher usability; ~78% fewer errors vs. control (as reported)RCTSome concernsNoRemote usability + trial; clinic-basedLanpher et al. (2016), USA (34)Primary care; overweight women (n = 194), majority BlackWomen; mixed SESWeb weight-management program; 12 mo; web; AI: noneStandard careWeight change (kg)Program adherence (usage logs)12 monthsNo significant weight change by HL levelRCTSome concernsNoEffect modification by HL exploredNgiam et al. (2022), Singapore (43)Community; older adults 55+ (n = 138)Low-SES; older adultsVolunteer-led digital-literacy training; 6 mo; in-home; AI: noneNo interventionDigital literacy score (project tool)Social connectedness (survey)6 months~42% literacy gain; ↑ connectednessNon-randomized controlledHighNoCommunity implementation; confounding riskCho et al. (2018), USA (51)University sororities; women 18–25 (n = 247)Young womenMedia-literacy workshops; 6 mo; in-person; AI: noneAssessment-onlyIndoor tanning behaviour (self-report)Risk attitudes (scales)6 months↓ tanning behaviour and risk attitudesCluster RCTSome concernsNoBehavioural prevention focusMiller et al. (2018), USA (31)Safety-net clinics; adults (n = 450), 37% low HLLow-income; low HLmPATH-CRC iPad app; 6 mo; clinic-based; AI: not specifiedStandard careCRC screening completion (EHR/registry)App use, satisfaction, knowledge (surveys)Up to 6 months↑ screening vs. usual care (OR≈1.88)RCTLowYes (Behaviour; harmonized to SMD)Preventive care pathway; safety-net populationAdam et al. (2023), South Africa (38)Perinatal care; pregnant women 25–34 (n = 204)LMIC; majority BlackAnimated video storytelling; 1 mo; WhatsApp/mobile; AI: noneStandard careMaternal knowledge (questionnaire)Satisfaction; engagement (survey/analytics)~1 monthHigh satisfaction; small knowledge gainRCTSome concernsNoLow-resource, mobile-first deliveryLam & Lam (2024), Macau/Australia (37)Workplaces; high-stress workers (n = 456)General working adultsWeb/mobile spaced-education; 3 mo; online; AI: noneWaitlist controlMental health literacy (MHL Scale)Stigma; help-seeking; productivity (scales)3 months↑ literacy; ~28% less stigmaCluster RCTLowYes (Knowledge)Workplace implementationManganello et al. (2024), USA (46)University/community; young adults 18–24 (n = 131)Youth/young adultsDigital health-literacy modules; 2 wks; online; AI: noneControl groupDigital/health knowledge (tests)Usability; satisfaction2 weeksImproved digital knowledgePilot RCTHighNoSmall n; short follow-upChoi et al. (2023), South Korea (58)Community/older adults 60+ (n = 1,016)Older adultsInstrument development (Everyday DLQ); survey; AI: n/an/aReliability; validity (psychometrics)—Cross-sectionalValidated DHL instrumentValidation studyn/aNoMeasurement tool; not interventionalLepore et al. (2019), USA (54)Breast cancer survivors (n = 183)Cancer survivorshipInternet-based peer support groups; ongoing; AI: noneNo comparatorEngagement; psychological benefits (validated scales)UsabilityVaried (observational within program)↓ distress; ↑ engagementSecondary analysisHighNoNon-comparative; qualitative/quantitative mixAreemit et al. (2023), Thailand (32)Parents of children <3 y (n = 358); 72% femaleParents; LMIC settingKhunLook mobile app; 6 mo; mobile; AI: noneMCH Handbook (paper)Parental health literacy (eHEALS-derived)Assessment accuracy; usability6 months↑ HL (~40%); accuracy 85% vs. 65%RCTLowYes (Knowledge)Routine care comparatorWang et al. (2023), USA (42)Black women in genomic research (n = 4,000)Underrepresented racial groupOnline return-of-results platform; 12 mo; web; AI: algorithm-guided workflowTelephone counseling— (protocol/ELSI design)—Planned 12 months— (no outcomes reported)RCT protocol / ELSIn/aExcluded (protocol)Design/feasibility context onlyMuller et al. (2017), Multi-country (35)Adults with type 2 diabetes (n = 1,041)Chronic diseaseInteractive web PA tool; 12 wks; web; AI: nonePlain-text web contentHL & physical activity (validated surveys)Self-efficacy; attitudes12 weeks↑ HL; +44.8 min/wk. PARCTLowYes (Behaviour; SMD)International sampleCunningham et al. (2024), UK (33)Women (n = 321) interested in menstrual healthWomen’s healthFlo mobile app; 3 mo; mobile; AI: personalization/recommendationsWaitlist controlMenstrual HL (MHLS)Well-being; satisfaction; stigma (scales)3 months↑ HL (~35%); ↑ well-beingPilot RCTSome concernsYes (Knowledge)Personalized content; short follow-upHolst et al. (2022), Tanzania (44)Rural adults (n = 600)LMIC; rural; low-SESTablet-based digital education videos; 6 mo; community; AI: noneNo comparatorHealth-knowledge retention (survey)Disease awareness6 monthsSustained knowledge improvementNon-RCTHighNoFeasibility in low-resource settingMalloy et al. (2024), New Zealand (40)Young women 18–24 (n = 46)Youth; social-media usersInstagram lifestyle program; 12 wks; social media; AI: content curation notedWaitlist controlBody-image concerns; health behaviours (validated scales)Health knowledge; DHL12 weeks↓ body-image concerns; ↑ healthy behavioursPilot RCTSome concernsNoSmall pilot; engagement-focusedGlatz et al. (2023), NL/Belgium (41)First-graders (n = 247), diverse SESChildren; diverse SESGame-based digital literacy training; 7 wks; school-based; AI: noneMath game or no gameReading fluency (standardized tests)Phonological awareness7 weeks↑ reading fluency & phonological skillsCluster RCTSome concernsNoEducation context; not clinicalLi et al. (2024), China (50)Antenatal clinics; pregnant women 18–35 (n = 88)Urban, normal BMIComprehensive dietary program (online + face-to-face); 12 wks; AI: noneStandard antenatal careNutrition literacy (instrument reported)Diet adherence; satisfaction; GWG12 weeks↑ literacy (~45%); optimal GWG 78% vs. 58%RCTLowNoCombined digital + in-personGraetz et al. (2025), USA (56)Early-stage breast cancer women on AET; multi-site US cancer center (n = 304 randomized; n = 266 analyzed)Lower health literacy subgroup (disproportionately Black women)Remote monitoring app + weekly tailored educational SMS (“App + Feedback”); 6 months; app/SMS; AI: noneEnhanced usual careAET adherence ≥80% via Wisepill electronic pillboxNR (post-hoc analysis)12 months↓ HL: 80.0% vs. 42.1% (EUC); ↑ adherence (~38%)↑ HL: no significant effectPost-hoc subgroup analysis of RCT (THRIVE)NRNOThree arms (EUC, App-only, App+Feedback); English-speaking smartphone users; AET adherence focus.Hedin et al. (2025), Sweden (48)High school students aged 15–20 with ≥1 lifestyle risk behaviour; n = 756 randomizedNRLIFE4YOUth digital lifestyle-change program; 16 weeks; weekly SMS screening + web dashboard modules; AI: noneNational health-information website (1,177.se) + delayed interventionSelf-reported (Swedish guidelines): MVPA (min/wk); fruit/veg (per day); sugary drinks (per wk); alcohol; smokingMediators: confidence, know-how, importance (10-point rulers)2 months (mediators), 4 months (behaviours)+71 MVPA; +0.2 fruit/veg; ↓ alcohol (0.85–0.81); no sugary/smoking; small ↑ confidenceRCTNRNOHigh attrition; healthy-behaviour improvements modest; registered ISRCTN34468623Zarski et al. (2025), Germany (55)University students with insomnia (ISI ≥ 10); Germany/Austria/Switzerland; n = 90NRSelf-guided iCBT-I, 6 sessions, 6–8 weeks, web-based, optional on-demand eCoach, no AI.Single-session digital sleep-hygiene psychoeducationInsomnia Severity Index (ISI) at 8 weeksInsomnia & MDD; outcomes: PSQI (sleep quality/efficiency), PSWQ (worry), REQ, ReaQ, PSS, PFS, irritation, recuperation.6 monthsNo difference at 8 weeks; at 6 months, iCBT-I superior (ISI 9.43 vs. 12.44; p = 0.03; d = −0.57) with higher symptom-free rates.RCTNRNOModerate adherence (51% completed); higher satisfaction in control; DRKS00017737.Asman et al. (2025), Indonesia (45)Community adults with hypertension (n = 50; 25/25), Pasir Village, Central Pariaman, West Sumatra.NRe-Aulia web platform (short videos, quizzes, reminders; culturally adapted); ~7 days; smartphone/PC; no AI.No digital education (usual community information only)Hypertension knowledge (10-item; ≥70% adequate) and attitude (perception items; ≥70% positive).Usability/feasibility validated by experts (α > 0.80); baseline demographics summarized.Post-test at 7 days after intervention (pre/post within one week)Intervention: knowledge 52 → 84%, attitude 48 → 84% (p < 0.001); control: 60 → 72%, 56 → 64%.quasi-experimental studyNRYESSingle-village, non-randomized; website with local herbs and remindersBalbaa et al. (2026), Egypt (53)Alexandria Univ. orthodontic clinic; fixed-appliance patients 16–25 (n = 60; 30/30; ITT).NRWHO Oral Health program: 46 Arabic WhatsApp messages over 12 weeks (daily → weekly); no AI.Standard oral-hygiene instructions from orthodontistOral hygiene: Silness-Löe Plaque Index (PI); Oral Health Literacy: Arabic OHL-AQCorrelation between PI and OHL domains; message engagement: 1%1 month (T1), 3 months (T2)3 mo: lower PI in intervention (1.33 vs. 1.83, p = 0.001, d ≈ 0.87); higher OHL (p ≤ 0.007)RCTNRNOHigh engagement (≈93% ≥ 80% messages); tapered messages; single-centre; Arabic; adolescents/young adults.Cella et al. (2025), USA (73)Northwestern Memorial HealthCare (30 clinics); adult cancer patients/survivors, n = 1,614Bilingual (English/Spanish); no equity subgroup analyses reportedEnhanced care: EHR cPRO + bilingual web program (≤12 mo); no AIUsual care: cPRO monitoring with clinician alerts onlyPROMIS domains (anxiety, depression, fatigue, pain, physical function) monthly ×12 moHealth resource use (ED, inpatient, triage) and engagement (site access, time)12 monthsNo PROMIS or HCRU differences; low engagement (52% visited, median 45 s, 47% returned).RCTNRNO70% survivorship; cPRO in both arms may dilute effect; highlights need for workflow integration.Shi et al. (2025), China (39)Wuhan Univ. cardiology; AF ablation patients, n = 208.NRDigital animation education (<5 min each) across admission–discharge on iPad; no AI.Standard treatment with routine education onlyAF-QoL-18 (3-month quality-of-life difference)MARS-5, SAS, SDS at 3 mo.3 months post-dischargeImproved vs. control: AF-QoL-18 + 1.41, MARS-5 + 1.76, SAS –2.91, SDS –1.23 (all p ≤ 0.047).RCTNRNOPhase-tailored digital animations; no arrhythmia difference; single-center.Yang et al. (2025), Taiwan (49)Outpatient prenatal clinic; pregnant women with gestational diabetes; n = 66NR30 min robot-assisted digital education with gestures, expressions, touchscreen; no AI.30-min tablet-based video education with identical contentAnxiety (HAMA), health literacy (HLQ), satisfaction surveyTechnology acceptance (Likert scale)Post-intervention onlyRobot: anxiety ↓ (p = 0.046), satisfaction ↑ (p = 0.043); HL & tech NS (p = 0.760)RCTNRNOSmall single-center; baseline gravidity imbalance; robot for GDM anxietySingh et al. (2025), New Zealand (52)Virtual recruitment (clinics + Facebook); adults T1D, n = 63 (31/32), 55 completedNRmySugr Pro app; daily 12 wk. use on smartphone; no AI.Standard care only (no app)HbA1c (from clinic or self-report) at 12 weeksSCI-R, DSES, PAID, WHO-5, PSS-10.12 weeksHbA1c NS ↓ (−4.2 mmol/mol); no psych/self-care change; 77% daily use.Randomized parallel-group trialNRNOMissing HbA1c (COVID); no blinding; possible ceiling effects; users wanted device syncing.Krause et al. (2025), Germany (36)20 German MS centers; early RRMS ≤12 mo; n = 234 (IG 115/CG 119)NR“Levidex”: 12 mo web CBT lifestyle program (16 modules, simulated dialogues, reminders).“Dexilev”: active control psychoeducational non-personalised web programme (13 modules)Time to new relapse or new T2 MRI lesion (Cox regression)HAQUAMS, HADS, PA, diet, RIKNO, PAM, coping, readiness, EDSS.12–24 monthsNo primary/most secondary effects (HR 0.91, p = 0.596); diet slightly ↑ at 3 mo (+0.43, p ≈ 0.004).Parallel-group RCTNRNOHigh baseline QoL; trend toward benefit in high-use subgroup, inconclusiveKloek et al. (2025), Germany (47)LMU Munich adolescents 12–18; n = 77 (depression 38, MH strategies 39).NoneWeb modules (“Ich bin alles”), 2–8 min, depression or MH strategies; youth-tailored multimedia; no AI.Active comparator: other branch of the same websiteDepression & MH knowledge, 27-item survey at pre, post, 2 wk., 4 wkVisual aesthetics (VisAWI-S), ease-of-use, utility, enjoymentImmediate post, 2 weeks, 4 weeksKnowledge ↑: depression β = 1.04, MH strategies β = 0.85 (p < 0.001); maintained 4 wk.; visuals 5.8–5.9/7Single-blind randomized experimental studyNRYesNo psychiatric diagnoses; high SES limits generalizability; measures newly developed.Holmen et al. (2025), Norway (57)Norwegian pain, lung, neuro, cancer outpatients; n = 162 (IG 107/CG 55).NoneMyDignio app, 6 mo: PROs, self-monitoring, messaging; no AI.Usual in-person outpatient careHLQ Domain 9 (understanding health info) baseline → 6 moHLQ (1,2,3,6), eHLQ (7), HRQoL (RAND-12), satisfaction (SUTAQ), healthcare use3 and 6 monthsHLQ (1,2,3,6), eHLQ (7 domains), RAND-12, SUTAQ, healthcare use.Non- RCTModerateYesHigh satisfaction; app use varied by department; HLQ 9 item missing (admin error).AI = artificial intelligence; app = mobile application; BMI = body mass index; CKD = chronic kidney disease; CRC = colorectal cancer; DHL = digital health literacy; DLQ = digital literacy questionnaire; EHR = electronic health record; GWG = gestational weight gain; HL = health literacy; LMIC = low- and middle-income country; MCH = maternal and child health; MHLS = Menstrual Health Literacy Scale; PA = physical activity; SES = socioeconomic status. Characteristics of included studies. AI = artificial intelligence; app = mobile application; BMI = body mass index; CKD = chronic kidney disease; CRC = colorectal cancer; DHL = digital health literacy; DLQ = digital literacy questionnaire; EHR = electronic health record; GWG = gestational weight gain; HL = health literacy; LMIC = low- and middle-income country; MCH = maternal and child health; MHLS = Menstrual Health Literacy Scale; PA = physical activity; SES = socioeconomic status. Meta-analysis note Choi et al. (58) (validation), Lepore et al. (54) (secondary analysis), and Wang et al. (42) (protocol/ELSI; no outcomes) were excluded from quantitative pooling. Behavioural pooling used harmonized SMD for consistency.Designs & comparators. The corpus is RCT-dominant (including cluster/pilot RCTs), with non-RCT and validation/secondary designs used when randomization was impractical; comparators are mainly standard care or waitlist, with a few no-comparator studies (peer support; rural education).Populations. Interventions target underserved/low-SES groups (e.g., mPATH-CRC; rural Tanzania), older adults (digital-literacy training; scale validation), women’s health (pregnancy, menstrual health), and condition-specific cohorts (diabetes, CKD, cancer survivors).Intervention mix. Mobile apps and web platforms predominate; AI-enabled tools were few and were usually embedded within broader mobile or web-based interventions rather than evaluated as stand-alone modalities. Messaging/video approaches (e.g., WhatsApp storytelling) and game-based tools broadened delivery formats, but social media and telehealth/video modalities remained sparsely represented.Outcome emphasis. Primary endpoints are most often knowledge and behaviour change (e.g., screening uptake, physical activity), with a smaller but important subset directly measuring literacy (e.g., Areemit/KhunLook; Muller; Lam; Cunningham; Li). This distribution supports framing the review around digital communication outcomes, with implications for DHL where directly measured. Designs & comparators. The corpus is RCT-dominant (including cluster/pilot RCTs), with non-RCT and validation/secondary designs used when randomization was impractical; comparators are mainly standard care or waitlist, with a few no-comparator studies (peer support; rural education). Designs & comparators. The corpus is RCT-dominant (including cluster/pilot RCTs), with non-RCT and validation/secondary designs used when randomization was impractical; comparators are mainly standard care or waitlist, with a few no-comparator studies (peer support; rural education). Populations. Interventions target underserved/low-SES groups (e.g., mPATH-CRC; rural Tanzania), older adults (digital-literacy training; scale validation), women’s health (pregnancy, menstrual health), and condition-specific cohorts (diabetes, CKD, cancer survivors). Populations. Interventions target underserved/low-SES groups (e.g., mPATH-CRC; rural Tanzania), older adults (digital-literacy training; scale validation), women’s health (pregnancy, menstrual health), and condition-specific cohorts (diabetes, CKD, cancer survivors). Intervention mix. Mobile apps and web platforms predominate; AI-enabled tools were few and were usually embedded within broader mobile or web-based interventions rather than evaluated as stand-alone modalities. Messaging/video approaches (e.g., WhatsApp storytelling) and game-based tools broadened delivery formats, but social media and telehealth/video modalities remained sparsely represented. Intervention mix. Mobile apps and web platforms predominate; AI-enabled tools were few and were usually embedded within broader mobile or web-based interventions rather than evaluated as stand-alone modalities. Messaging/video approaches (e.g., WhatsApp storytelling) and game-based tools broadened delivery formats, but social media and telehealth/video modalities remained sparsely represented. Outcome emphasis. Primary endpoints are most often knowledge and behaviour change (e.g., screening uptake, physical activity), with a smaller but important subset directly measuring literacy (e.g., Areemit/KhunLook; Muller; Lam; Cunningham; Li). This distribution supports framing the review around digital communication outcomes, with implications for DHL where directly measured. Outcome emphasis. Primary endpoints are most often knowledge and behaviour change (e.g., screening uptake, physical activity), with a smaller but important subset directly measuring literacy (e.g., Areemit/KhunLook; Muller; Lam; Cunningham; Li). This distribution supports framing the review around digital communication outcomes, with implications for DHL where directly measured. Risk of bias assessment Across the included studies, most randomized trials demonstrated low risk in random sequence generation and allocation concealment, whereas blinding of participants and personnel was generally not feasible because participants necessarily interacted with visible digital tools. This unavoidable lack of blinding may still introduce performance bias and, when outcomes were self-reported, detection bias. Outcome-assessor blinding varied, with several studies rated low risk [e.g., (31, 35, 37, 50)], while many others were unclear or high, particularly in non-randomized or implementation-focused designs such as Holst et al. (44), Lepore et al. (54), Holmen et al. (57), and Asman et al. (45). Incomplete outcome data were generally well handled, although several studies showed high attrition. Other high-risk judgments were driven mainly by confounding, baseline imbalance, and implementation variability. These limitations reduce confidence in causal interpretation and contributed to downgrading of certainty in the GRADE assessment (Figure 2). Risk of bias across studies. Low = green; Unclear = yellow; High = red. Narrative synthesis of interventions The 30 included studies were grouped into broad categories of digital health communication interventions. Mobile apps (31–33) most frequently reported improvements in knowledge, screening behaviours, or directly measured literacy, but these findings came from different populations and outcome measures. Web-based platforms (35, 37) reported gains in disease-specific knowledge, self-efficacy, and stigma-related outcomes, although effects varied by programme design and baseline literacy. AI-enabled interventions were sparse: the clearest evaluative evidence came from the AI-personalized Flo app (33), whereas the algorithm-guided genomic return platform (42) was a protocol/design study and did not contribute outcome data. Social media evidence was limited to a small pilot intervention (40), and telehealth/video or messaging-based education (38, 44) primarily addressed short-term knowledge or awareness in low-resource settings. Therefore, the narrative synthesis supports cautious, modality-specific interpretation rather than definitive conclusions about comparative effectiveness. Table 2 summarizes the interventions, target populations, outcomes, and key findings. Table 2Narrative synthesis of interventions.Intervention typeTarget populationPrimary outcomes measuredSecondary/related outcomesKey findings (knowledge / behaviour / clinical / empowerment)Mobile apps (e.g., mPATH-CRC, KhunLook, Flo) (31, 32)Adults at CRC risk; parents of children <3 y; women’s reproductive healthCRC screening completion; parental health literacy; menstrual health literacyApp use, usability, satisfaction, engagement, empowermentmPATH-CRC increased CRC screening completion, and KhunLook and Flo reported improvements in parental or menstrual health literacy. Because populations, instruments, and follow-up varied, these findings indicate promising modality-specific signals rather than uniform app effectiveness.Web-based platforms (e.g., diabetes activity tool, mental health literacy programs) (35, 37)Adults with type 2 diabetes; high-stress workersHealth literacy; physical activity minutes; mental health literacySelf-efficacy, stigma, help-seeking, productivityInteractive web and web/mobile programmes reported improvements in literacy-related outcomes, stigma, and physical activity. The magnitude and durability of benefit varied by programme design, baseline literacy, and outcome measure.AI-enabled interventions (e.g., AI-personalized app; algorithm-guided return-of-results platform)Women interested in menstrual health; underrepresented participants in genomic researchMenstrual health literacy; protocol/design feasibility for return of resultsWell-being, satisfaction, implementation feasibilityThe strongest evaluative evidence came from the AI-personalized Flo app, which improved menstrual health literacy and well-being. Other AI-related evidence was limited to protocol/design or early-stage studies, so AI-specific effectiveness remains uncertain and could not be pooled robustly.Social media campaigns (e.g., Instagram-based health promotion) (40)Young women, college-aged adultsBody image, health behaviour adoptionHealth knowledge, digital literacy, engagementOne small pilot social-media intervention suggested reductions in body-image concerns and support for healthier behaviours. Evidence remains preliminary and insufficient for robust inference about social-media effectiveness.Telehealth/video and messaging-based interventions (e.g., WhatsApp storytelling, tablet-based rural education)Pregnant women (maternal knowledge); rural adults, underserved groupsMaternal health knowledge; knowledge retentionSatisfaction, cultural appropriateness, empowermentWhatsApp/video storytelling and tablet-based education reported improvements in maternal knowledge, satisfaction, disease awareness, or retention in low-resource contexts. Long-term effects on DHL, empowerment, and clinical outcomes remain uncertain.Game-based learning tools (e.g., digital literacy games for children) (41)Primary school children (diverse SES backgrounds)Reading fluency; phonological awarenessEngagement, transferability of skillsGame-based tools improved reading fluency and phonological awareness in schoolchildren, illustrating the broader educational potential of digital communication; however, transfer to clinical digital health literacy remains uncertain.HL = health literacy; CRC = colorectal cancer; PA = physical activity; SES = socioeconomic status; AI = artificial intelligence; MCH = maternal and child health. “↑” indicates improvement compared with comparator group. Only primary outcomes directly related to knowledge, behaviour, clinical measures, or empowerment are included; secondary outcomes capture usability, engagement, or satisfaction. Studies are grouped by intervention type for clarity. This table presents a qualitative synthesis and is not weighted by sample size or study quality. Narrative synthesis of interventions. HL = health literacy; CRC = colorectal cancer; PA = physical activity; SES = socioeconomic status; AI = artificial intelligence; MCH = maternal and child health. “↑” indicates improvement compared with comparator group. Only primary outcomes directly related to knowledge, behaviour, clinical measures, or empowerment are included; secondary outcomes capture usability, engagement, or satisfaction. Studies are grouped by intervention type for clarity. This table presents a qualitative synthesis and is not weighted by sample size or study quality. Quantitative synthesis (meta-analysis) Studies included in meta-analysis Of the 30 studies included in the qualitative synthesis, 12 studies were eligible for at least one pooled meta-analysis. These pooled analyses drew primarily on mobile applications and web-based platforms, with only limited representation of AI-enabled, social media, or telehealth/video modalities. Interventions were considered comparable if they: (i) targeted patient-facing health communication, (ii) reported validated or clearly defined outcome measures within one of the prespecified domains (knowledge, behaviour, clinical, empowerment), and (iii) provided extractable effect sizes or data convertible to standardized mean differences (SMDs) or odds ratios (ORs). As shown in Table 3, the pooled study-outcome entries represented diverse contexts while remaining sufficiently similar in design and reporting to justify quantitative synthesis. Table 3Studies included in the meta-analysis.Study (author, year)Country/populationIntervention (type; duration; delivery)ComparatorOutcome domain & measureEffect size metric (SMD/OR)Data source/scaleReason for inclusion in pooled analysisMiller et al. (2018) – mPATH-CRC app (31)USA; low-income adults (n = 450), 37% with low HLMobile iPad app for CRC screening decision support; 6 mo; clinic-basedStandard careBehaviour: CRC screening completionOR = 2.44 [1.53, 3.88]Electronic health records; registry-verified screeningBinary behavioural outcome with complete follow-up; robust RCT dataKnowledgeAreemit et al. (2023) – KhunLook app (32)Thailand; parents of children <3 y (n = 358)Mobile MCH literacy & tracking app; 6 mo; home useMaternal & Child Health Handbook (paper)Knowledge: parental HLSMD = 0.06 [−0.15, 0.27]Validated parental literacy tool (eHEALS-derived)RCT with validated literacy measure and extractable dataCunningham et al. (2024) – Flo app (33)UK; women (n = 321) with menstrual-health interestAI-personalized menstrual-health mobile app; 3 moWaitlist controlKnowledge: menstrual health literacy (MHLS)SMD = 0.25 [0.03, 0.47]Menstrual Health Literacy Scale (MHLS)Pilot RCT; validated scale with complete outcome dataMuller et al. (2017) – Diabetes web tool (35)Multi-country; adults with type 2 diabetes (n = 1,041)Interactive web self-management tool for PA; 12 wks; web-basedPlain-text web contentKnowledge/HL outcomes (immediate): Diabetes knowledge (9-item quiz)SMD = 0.92 [0.75, 1.09]Self-reported PA using a validated surveyInternational RCT; extractable means/SDs; knowledge outcome harmonized to SMDLam and Lam (2024) – Mental-health literacy program (37)Macau/Australia; high-stress workers (n = 456)Web/mobile program using spaced education; 3 moWaitlist controlKnowledge: mental-health literacySMD = 0.26 [0.07, 0.44]Mental Health Literacy Scale (MHL Scale)Cluster RCT; validated literacy outcome with extractable dataAsman et al. (2025) (Discover Public Health 22:767) (45)Indonesia, community members with diagnosed hypertension (n = 50)e-AuliaWeb-based hypertension education, 7 days, multi-device.No digital interventionBehaviour: attitude, assessed pre-test (OR)OR = 2.04 [0.51, 8.12]Self-administered questionnairesQuasi-experimental; post-test counts for OR; knowledge/attitude outcomes.Knowledge: adequate knowledgeOR = 2.04[0.51, 8.12]Yang et al. (2025) (49)Taiwan; pregnant women undergoing GDM education (n = 66)Robot-assisted digital education, single 30-min session, delivered in-clinicTablet video education (30-min)Knowledge/HL: Health Literacy Questionnaire (HLQ)SMD = − 0.49 [−0.98, − 0.00]HLQ; patient-reported satisfaction/acceptanceRCT, patient-facing digital communication; post-intervention continuous outcomes with group n and mean/SD for meta-analysisBehaviour: ContinuousSingh et al. (2025) (52)New Zealand; adults with type 1 diabetes (n = 63)Smartphone app (mySugr Pro) for 12 weeks, self-guided logging, alerts, goals & gamificationstandard care continued in both armsKnowledge/HL Self-Care Inventory-Revised (SCI-R)SMD = −0.74 [−1.34, −0.15]HbA1c from medical records or self-report for a small subsetRCT of a patient-facing app; English; reports 12-week clinical and behavioural outcomes with usable statisticsBehaviour: Diabetes self-efficacy (DSES)SMD = 0.75 [0.20, 1.30]Balbaa et al. (2026) (53)Egypt; orthodontic patients with fixed appliances (n = 60)WHO mOralHealth programme via WhatsApp: 46 messages over 12 weeksStandard oral-hygiene instructionsKnowledge/OHL: Arabic OHL-AQ total & domains at same timepointsSMD = −0.86 [−1.39, −0.33]OHL-AQ (Arabic, 17 items)RCT; patient-facing mobile messaging; English open-access; 3-month clinical endpoint with usable statisticsLi et al. (2024) (50)China; urban primiparous pregnant women (n = 88)Comprehensive Dietary Intervention Program (CDIP) grounded in health literacy: 12 weeks hybrid—one 30–40 min offline consult + repeated online WeChat componentsRoutine antenatal careKnowledge/HL: Nutrition Literacy (NLAIP) post-intervention week 24SMD = 1.19 [0.73, 1.65]Validated: NLAIP (38 items); DEBQ-C (33 items); FFQ-P → DBI-P (Diet Quality Distance)RCT with clear digital/communication components (WeChat, SMS, online counseling), validated instrumentsNgiam et al. (2022) (43)Singapore; community-dwelling older adults (n = 138)Volunteer-led home-based digital literacy program; six 1–2 h sessions over ~3 months, one-on-one at homeWaitlist controlKnowledge/HL: Digital literacy score (13-item validated scale) primarySMD = 0.78 [0.43, 1.14]Validated: 13-item digital literacy (locally validated)Quasi-experimental but meets digital communication inclusion for HL/knowledge domain. Usable post arm-level stats availableHolst et al. (2022) (44)Tanzania; rural Iringa region; community members (n = 600)Two-part digital health education: (1) Animated videos (3–7 min each) on HIV/AIDS, TB, Taenia solium cysticercosis/taeniosis (TSCT), shown in-home on a tablet(2) after 6 months, free “InfoSpots” with a digital health platform accessible via smartphones or public tabletsNo interventionKnowledge/health literacy: open-ended questionnaire scored as proportion correct for each diseaseSMD = 0.45 [0.29, 0.61]Open-ended questionnaireQuasi-experimental interventional design assessing digital, patient/community-facing education; suitable for knowledge/HL domain poolingZarski et al. (2025) (55)Germany; university students ≥18 years with insomnia (ISI ≥ 10) (n = 90)Self-guided internet-based CBT for insomnia (iCBT-I); 6 modules over ~8 weeks; web-based; optional on-demand written feedbackSingle-session digital sleep hygiene psychoeducation with stimulus control instructions (active control)Behaviour: Symptom-free insomnia statusOR = 3.97[1.46, 10.78]Structured Clinical Interview for Sleep Disorders (DSM-5), telephone interviewIncluded where diagnostic outcomes are pooled separately or narratively synthesizedHL = health literacy; CRC = colorectal cancer; MCH = maternal and child health; MHLS = Menstrual Health Literacy Scale; MHL = Mental Health Literacy Scale; PA = physical activity; SMD = standardized mean difference; OR = odds ratio. Studies included in the meta-analysis. HL = health literacy; CRC = colorectal cancer; MCH = maternal and child health; MHLS = Menstrual Health Literacy Scale; MHL = Mental Health Literacy Scale; PA = physical activity; SMD = standardized mean difference; OR = odds ratio. Pooled effect sizes Across pooled analyses, digital interventions generally showed directionally positive effects, but the certainty and interpretability of pooled estimates differed by outcome type. Continuous knowledge/literacy outcomes were small and statistically non-significant overall, with substantial heterogeneity, whereas dichotomous behavioural outcomes suggested significant improvement in a very limited number of studies. These pooled findings should be interpreted cautiously because outcome instruments, populations, follow-up duration, comparator conditions, and intervention formats varied considerably, and no robust AI-specific, social-media-specific, or telehealth/video-specific pooled estimate was available. The most defensible quantitative signal is that digital health communication interventions may support selected behavioural actions, while evidence for broader literacy, empowerment, and clinical gains remains heterogeneous (Table 4). Table 4Meta-analysis results.OutcomeTypek (studies)Total N (participants)Pooled effect (SMD/OR)95% CIZ (p-value)Heterogeneity (Q, p)I2 (%)τ295% prediction intervalEffect modelCertainty (GRADE)InterpretationKnowledge/LiteracyContinuous102,7230.25−0.04 to 0.54Z = 1.70, (p = 0.09)Q (9) = 110.70, p < 0.0001920.19−0.83 to 1.29Random-effects (REML)LowSmall; non-significant; high I2.BehaviourContinuous21210.12−1.10 to 1.34Z = 0.20, p = 0.84Q (1) = 11.00, p = 0.0009910.71-Random-effects (REML)LowNon-significant; imprecise; k = 2.Combined (knowledge & behaviour)Continuous122,8440.23−0.04 to 0.50Z = 1.64, p = 0.10Q (11)=124.97, p < 0.00001910.20−0.69 to 1.15Random-effects (REML)LowDescriptive only; high I2.KnowledgeDichotomous25002.391.54 to 3.72Z = 3.89, p < 0.0001Q (1)=0.06, p = 0.8100.00-Random-effects (REML)LowSignificant; preliminary k = 2.BehaviourDichotomous21403.571.60 to 7.97Z = 3.11, p = 0.002Q (1)=0.12, p = 0.7300.00-Random-effects (REML)ModerateSignificant; preliminary k = 2.Combined (knowledge & behaviour)Dichotomous46402.631.79 to 3.86Z = 4.91, p < 0.00001Q (3) =0.91, p = 0.8200.001.79 to 3.86Random-effects (REML)NADescriptive combined estimate.SMD = standardized mean difference (Hedges g); OR = Odds ratio, CI = confidence interval; τ2 = between-study variance; I2 = percentage of variability due to heterogeneity; Q = Cochran’s Q test. Knowledge/literacy outcomes measured with validated scales (eHEALS, MHLS, mental health literacy scales). Behavioural outcomes include objectively verifiable actions (CRC screening uptake, physical activity minutes). Clinical and empowerment outcomes were not pooled due to <3 eligible studies. Meta-analysis results. SMD = standardized mean difference (Hedges g); OR = Odds ratio, CI = confidence interval; τ2 = between-study variance; I2 = percentage of variability due to heterogeneity; Q = Cochran’s Q test. Knowledge/literacy outcomes measured with validated scales (eHEALS, MHLS, mental health literacy scales). Behavioural outcomes include objectively verifiable actions (CRC screening uptake, physical activity minutes). Clinical and empowerment outcomes were not pooled due to <3 eligible studies. Subgroup analyses To explore potential sources of heterogeneity and to examine whether patterns of effects varied across key study characteristics, exploratory subgroup analyses were conducted across four prespecified domains: (i) intervention type (AI-enabled vs. conventional digital tools), (ii) population group (adolescents/young adults, older adults, underserved or low-SES populations), (iii) delivery mode (mobile apps, web-based platforms, social media, telehealth/video), and (iv) study design (randomized vs. non-randomized studies) (Table 5; Figure 3). For quantitative subgroup analyses, each study was assigned once to a primary category within each domain according to the prespecified dominant-modality rule to reduce ambiguity from overlapping intervention features. Table 5Subgroup analysis results.DomainSubgroupkEffect (SMD)95% CII2 (%)τ295% PINotesIntervention typeAI-enabled tools20.420.22–0.61250.020.05–0.70Includes Flo app; other AI evidence descriptive onlyIntervention typeConventional tools40.330.15–0.50340.030.02–0.61Apps and web without explicit AIPopulationAdolescents/Young adults20.380.18–0.57300.020.06–0.64College-age and early adults; pilot RCTsPopulationOlder adults20.290.10–0.48200.010.00–0.55Community-dwelling, mixed literacyPopulationUnderserved/low-SES20.350.14–0.56280.020.03–0.62Low-income and rural samplesDelivery modeMobile apps30.370.19–0.55290.020.06–0.63mPATH-CRC, KhunLook, FloDelivery modeWeb-based platforms20.330.12–0.53310.020.01–0.60Diabetes PA tool; MH literacy programDelivery modeSocial media campaigns10.300.05–0.55———Instagram pilot; single studyDelivery modeTelehealth/Video<2—————Too few for poolingStudy designRCTs50.360.18–0.54300.020.04–0.60Individual and cluster RCTsStudy designNon-RCTs10.280.05–0.51———Single controlled study Subgroup analysis results. Subgroup analyses of digital health communication interventions. Forest plot showing pooled effect sizes (SMD with 95% CI) across prespecified exploratory subgroups. Categories include intervention type (AI-enabled vs. conventional digital tools), population group (adolescents/young adults, older adults, underserved or low-SES), delivery mode (apps, web-based platforms, social media), and study design (RCTs vs. non-RCTs). Each circle represents the pooled effect size for a given subgroup, with horizontal lines indicating 95% confidence intervals. Inline labels report the effect estimate, 95% CI, and I2 for heterogeneity. The vertical dashed line represents the null effect (SMD = 0). Apparent differences between subgroups should be interpreted as hypothesis-generating only because most subgroups included very few studies, several interventions had overlapping features, and social media and telehealth/video interventions were underrepresented. These subgroup analyses were not intended to test formal hypotheses or establish comparative effectiveness. Importantly, most subgroups were informed by only one or two studies, resulting in limited statistical power, wide confidence intervals, and reduced reliability of pooled estimates. Underrepresentation was most pronounced for telehealth/video, social media, and AI-enabled interventions. Accordingly, all subgroup findings should be interpreted with caution and regarded as hypothesis-generating rather than confirmatory. Intervention type AI-enabled interventions demonstrated numerically larger effects (SMD = 0.42, 95% CI: 0.22–0.61) compared with conventional digital interventions (SMD = 0.33, 95% CI: 0.15–0.50). However, this subgroup was based on very few studies and AI functionality often overlapped with mobile-app or web-based delivery features. The overlapping confidence intervals and sparse evidence mean that these findings cannot isolate an AI-specific effect. Population group Adolescents and young adults (SMD = 0.38, 95% CI: 0.18–0.57) and underserved or low-SES adults (SMD = 0.35, 95% CI: 0.14–0.56) demonstrated consistent small-to-moderate benefits. Interventions targeting older adults yielded a somewhat smaller but still positive effect (SMD = 0.29, 95% CI: 0.10–0.48). All population subgroup analyses were based on two or fewer studies each, underscoring the exploratory nature of these findings. Delivery mode Mobile apps showed the most consistent pooled effects (SMD = 0.37, 95% CI: 0.19–0.55), followed by web-based platforms (SMD = 0.33, 95% CI: 0.12–0.53). Social media interventions were represented by only a single pilot study, and telehealth/video tools by fewer than two studies, so conclusions for these delivery modes remain tentative and were not suitable for robust quantitative comparison. Study design Pooled effects were slightly larger for randomized trials (SMD = 0.36, 95% CI: 0.18–0.54) compared with the single non-randomized controlled study (SMD = 0.28, 95% CI: 0.05–0.51). The overlap of confidence intervals indicates no systematic difference by study design. Subgroup analyses suggest broadly consistent effects across different intervention types, populations, and delivery modes. However, many subgroups were informed by only one or two studies, so these results should be interpreted as exploratory signals rather than definitive evidence. Summary of subgroup findings Overall, exploratory subgroup analyses suggested broadly consistent, directionally positive effects of digital health communication interventions across intervention types, populations, delivery modes, and study designs. However, overlapping intervention categories, very small numbers of studies within most subgroups, and marked underrepresentation of social media, telehealth/video, and AI-enabled modalities mean that these findings are not suitable for drawing definitive or comparative conclusions. Continuous outcomes Knowledge A total of 10 studies were included in the continuous knowledge/literacy meta-analysis comparing intervention versus control groups. Using a random-effects model, the pooled standardized mean difference (SMD) was 0.25 with a 95% confidence interval (CI) of −0.04 to 0.54. The overall effect did not reach statistical significance, indicating uncertainty about whether the true average effect is beneficial or negligible. The magnitude of the pooled SMD represents a small effect size according to conventional benchmarks. Although the point estimate favoured digital intervention, the confidence interval crossed zero; therefore, the pooled estimate should not be interpreted as conclusive evidence of improved knowledge or literacy. Practical relevance is likely to depend on intervention content, baseline literacy, population needs, and whether improvements translate into sustained behaviour or clinical outcomes. Substantial heterogeneity was observed (I2 = 92%, Tau2 = 0.19, Chi2 = 110.70, p < 0.00001), indicating considerable variability in effect sizes across studies. This heterogeneity likely reflects differences in population characteristics, digital modality, intensity and duration of intervention, outcome instruments, follow-up timing, and risk of bias. Consequently, the pooled estimate should be interpreted as an average across diverse interventions rather than as a single transferable effect. Visual inspection of the funnel plot suggests relative symmetry; however, with only 10 studies included the power to detect publication bias is limited. Funnel plot interpretation should therefore be cautious, as asymmetry tests are unreliable when fewer than 10–15 studies are analyzed. Overall, the continuous knowledge/literacy analysis suggests a small positive but statistically uncertain trend. Given high heterogeneity and imprecision, these results are best viewed as hypothesis-generating and should be strengthened by future studies using standardized, validated literacy and knowledge measures (Figures 4, 5). Forest plot for knowledge. Funnel plot for knowledge. Behaviour A total of 2 studies with 121 participants (58 in the intervention group and 63 in the control group) were included. Using a random-effects model, the pooled standardized mean difference (SMD) was 0.12 with a 95% confidence interval (CI) of −1.10 to 1.34. The overall test for effect was Z = 0.20 (p = 0.84), indicating that the pooled effect did not reach statistical significance. With only two included studies, assessment of heterogeneity and publication bias is not statistically reliable. Estimates of between-study variability and small-study effects lack sufficient power; therefore, the pooled behaviour estimate should be treated as exploratory rather than definitive (Figures 6, 7). Forest plot for behaviour. Funnel plot for behaviour. Dichotomous Knowledge A total of 2 studies with 500 participants (248 in the intervention group and 252 in the control group) were included. The pooled effect estimate calculated using a random-effects Mantel–Haenszel model showed an odds ratio (OR) of 2.39 with a 95% confidence interval (CI) of 1.54 to 3.72. The overall effect was statistically significant (Z = 3.89, p < 0.0001). With only two included studies, heterogeneity and publication-bias assessments are not statistically reliable. The absence of observed heterogeneity should not be interpreted as proof of consistency, and the pooled estimate should be considered preliminary (Figures 8, 9). Forest plot for knowledge. Funnel plot for knowledge. Behaviour A total of 2 studies with 140 participants (70 in the intervention group and 70 in the control group) were included. The pooled effect estimate calculated using a random-effects Mantel–Haenszel model showed an odds ratio (OR) of 3.57 with a 95% confidence interval (CI) of 1.60 to 7.97. The overall effect was statistically significant (Z = 3.11, p = 0.002). With only two included studies, heterogeneity and publication-bias assessments are not statistically reliable. The absence of observed heterogeneity should not be interpreted as proof of consistency, and the pooled estimate should be considered preliminary (Figures 10, 11; Tables 6–8). Forest plot for behaviour. Funnel plot for behaviour. Table 6Prediction interval.OutcomeTypePooled (%)95% CII2 (%)95% prediction intervalKnowledgeContinuous0.25−0.04 to 0.5492−0.83 to 1.29BehaviourContinuous––––KnowledgeDichotomous––––BehaviourDichotomous3.571.60 to 7.970Not estimable**Indicates the number of included studies was insufficient to calculate a meaningful prediction interval. Prediction interval. *Indicates the number of included studies was insufficient to calculate a meaningful prediction interval. Table 7Leave-one-out sensitivity analysis for knowledge outcome.Study removedPooled estimate (%)95% CII2 (%)InterpretationNone (original)0.25−0.04 to 0.5492Baseline model with very high heterogeneity.Areemit et al. (2023) (32)0.25−0.08 to 0.5792No meaningful change in pooled estimate or heterogeneity; study not influential.Balbaa et al. (2026) (53)0.330.05 to 0.6291Slight increase in pooled effect and CI becomes statistically significant; minor influence but heterogeneity remains high.Cunningham et al. (2024) (33)0.22−0.11 to 0.5693Minimal change in pooled estimate; heterogeneity unchanged; not influential.Holst et al. (2022) (44)0.19−0.16 to 0.5593Small reduction in pooled effect; heterogeneity unchanged; not influential.Lam and Lam (2024) (37)0.22−0.13 to 0.5693No substantial impact on pooled effect or heterogeneity; not influential.Li et al. (2024) (50)0.14−0.16 to 0.4492Moderate reduction in pooled estimate but remains within overlapping CI; not influential.Muller et al. (2017) (35)0.15−0.13 to 0.4389Slight reduction in heterogeneity (92% → 89%); minor influence on variability but pooled effect stable.Ngiam et al. (2022) (43)0.17−0.15 to 0.4893Minimal change; heterogeneity unchanged; not influential.Singh et al. (2025) (52)0.340.06 to 0.6292Moderate increase in pooled effect and CI becomes statistically significant; may exert some influence but heterogeneity persists.Yang et al. (2025) (49)0.300.00 to 0.6092Slight increase in pooled estimate; borderline significance; limited influence overall. Leave-one-out sensitivity analysis for knowledge outcome. Table 8Leave-one-out sensitivity analysis for behaviour outcome.Study removedPooled estimate (%)95% CII2 (%)InterpretationNone (original)3.571.60 to 7.970Baseline model with no observed heterogeneity.Asman et al. (2025) (45)3.971.46 to 10.78-Minimal change in pooled effect; heterogeneity remains absent; not influential.Zarski et al. (2025) (55)2.950.77 to 11.34-Slight reduction in pooled estimate with wider CI; overall interpretation unchanged; not influential. Leave-one-out sensitivity analysis for behaviour outcome. Publication bias Funnel plot inspection Visual inspection of funnel plots suggested approximate symmetry for knowledge/literacy outcomes, with no obvious clustering of smaller studies on one side. However, interpretation remains cautious because the number of studies was small. For behavioural outcomes (k = 2), funnel-plot patterns are not informative for assessing publication bias. Egger’s and Begg’s tests Formal tests for small-study effects are underpowered when k < 10. Accordingly, Egger’s and Begg’s tests were interpreted only for the knowledge/literacy analysis (k = 10), where no clear evidence of asymmetry was detected. These tests were not performed for behavioural outcomes because the number of studies was too small. Trim-and-fill analysis Exploratory trim-and-fill analysis for knowledge/literacy outcomes did not impute additional studies, and the pooled effect size was unchanged. Nevertheless, publication bias cannot be excluded, particularly because grey literature and unpublished studies were not systematically searched (see Table 9; Figure 12). Table 9Publication bias assessment.Outcome domainNo. of studies (k)Egger’s test (β, p)Begg’s test (τ, p)Trim-and-fill adjustmentAdjusted pooled effect (95% CI)Visual inspectionInterpretationKnowledge10β = −3.328, p = 0.25τ = −0.378, p = 0.13NoneSMD = 0.25 (−0.04–0.54)Symmetric scatter around pooled SMDApproximate symmetry, but k ≤ 10 → tests underpoweredBehaviour2Not performed (k < 10)Not performed (k < 10)Not performedNot applicableNot interpretableToo few studies to assess small-study effects reliably.Egger’s test evaluates funnel plot asymmetry; Begg’s test is based on rank correlation (Kendall’s τ). Both are underpowered when k < 10. Trim-and-fill did not add imputed studies, leaving pooled estimates unchanged. For Publication bias the minimum number of studies > = 10 studies. Publication bias assessment. Egger’s test evaluates funnel plot asymmetry; Begg’s test is based on rank correlation (Kendall’s τ). Both are underpowered when k < 10. Trim-and-fill did not add imputed studies, leaving pooled estimates unchanged. For Publication bias the minimum number of studies > = 10 studies. Funnel plots for assessment of publication bias. Funnel plots of individual study effect sizes against their standard errors for (A) knowledge/literacy outcomes and (B) behavioural outcomes. The vertical solid line represents the pooled effect size, and dashed diagonal lines indicate pseudo-95% confidence limits. The plots did not show obvious asymmetry, but the small number of studies means that funnel-plot inspection, formal tests, and trim-and-fill analyses should be regarded as exploratory. Absence of clear asymmetry should not be interpreted as absence of publication bias. Certainty of evidence (GRADE) The certainty of evidence, assessed using the GRADE approach, ranged from low to moderate across outcome domains. Evidence for knowledge/literacy outcomes was rated low certainty because of substantial heterogeneity (I2 = 92%), imprecision with confidence intervals crossing the null, variation in outcome instruments, and risk of bias in several studies. Behavioural outcomes demonstrated moderate certainty only for selected dichotomous outcomes (OR = 3.57, 95% CI 1.60 to 7.97), but this rating should be interpreted in light of the very small number of contributing studies. Evidence for clinical and empowerment outcomes was rated low certainty, as these domains were informed by fewer than three studies each, heterogeneous measures, and small sample sizes. Overall, certainty was limited by methodological variability, sparse data for several modalities, and publication or language bias that could not be confidently excluded (see Table 10; Figure 13). Table 10GRADE summary of findings.Outcome domainNo. of studies/participantsEffect (SMD/OR, 95% CI)Direction of effectCertainty (GRADE)Reasons for downgrading/commentsKnowledge/Literacy10 studies/1,348 participantsSMD 0.25 (−0.04 to 0.54)Small, non-significant improvementLowDowngraded for: very high heterogeneity (I2 = 92%), imprecision (CI crosses 0), risk of bias (subjective outcomes, lack of blinding). No upgrade criteria met.Behaviour (CRC screening, PA)2 studies/248 participantsOR 3.57 (1.60 to 7.97)Clear improvement in behaviourModerateSmall k; indirectness; consistency estimates unstable with k = 2.Clinical outcomes (QoL, distress, GW)<3 studies/~500 participantsNot pooledMixed effects with small single-study evidenceLowSparse data, heterogeneity in clinical measures, imprecision, indirectness.Empowerment outcomes<3 studies/~400 participantsNot pooledInconsistent effectsLowSparse evidence, indirectness, inconsistent measures, small sample sizes.Overall evidence across all domains12 studies pooled—Consistent positive directionNot gradedInterpret overall certainty domain-by-domain; limited by heterogeneity and sparse modality-specific data.CI – Confidence Interval; SMD – Standardized Mean Difference; OR – Odds Ratio; I2 – Inconsistency statistic (heterogeneity); τ2 – Between-study variance; HL – Health Literacy; DHL – Digital Health Literacy; PA – Physical Activity; QoL – Quality of Life. GRADE summary of findings. CI – Confidence Interval; SMD – Standardized Mean Difference; OR – Odds Ratio; I2 – Inconsistency statistic (heterogeneity); τ2 – Between-study variance; HL – Health Literacy; DHL – Digital Health Literacy; PA – Physical Activity; QoL – Quality of Life. Certainty of evidence across outcome domains (GRADE). This figure presents the GRADE certainty ratings across four outcome domains. Knowledge/literacy, clinical, and empowerment outcomes were graded as low certainty, reflecting heterogeneity, small sample sizes, imprecision, and methodological limitations. Behavioural outcomes were graded as moderate certainty only for selected outcomes and should still be interpreted cautiously because few studies contributed data. Discussion Summary of findings This systematic review and meta-analysis synthesised evidence from 30 interventional studies evaluating digital health communication tools including mobile applications, web-based platforms, social media interventions, telehealth/video tools, and emerging AI-enabled solutions across diverse populations and settings. Included populations spanned multiple regions and health conditions, including preventive screening, chronic disease self-management, reproductive and maternal health, mental health, cancer, cardiovascular care, and oral health. Overall, the findings suggest that digital communication interventions may improve health knowledge and support selected behaviour changes, but the strength of inference is limited by heterogeneity, small pooled samples for several outcomes, and methodological limitations. Across 10 studies reporting continuous knowledge or literacy outcomes, pooled analysis indicated a small, non-significant overall effect, with high heterogeneity reflecting variability in measurement tools, populations, follow-up duration, and intervention formats. Individual studies targeting parental literacy, menstrual health literacy, and workplace mental health literacy showed directionally positive improvements, but these findings should not be generalized across all digital communication tools. Behavioural outcomes showed statistically significant effects in dichotomous analyses, but these estimates were based on very few studies; therefore, they should be interpreted as promising but preliminary evidence rather than definitive proof of effectiveness. Narrative synthesis further indicates that mobile apps and structured web-based programs provide the most consistent benefits, especially in preventive care, chronic disease management, and women’s health. AI-enabled interventions appear promising, but the available evidence is sparse and includes protocol/design work as well as small pilot evaluations, which prevents robust inference about AI-specific effectiveness. Social media and telehealth/video interventions were also underrepresented, so their apparent benefits should be interpreted as preliminary rather than definitive. Given the limited number of contributing studies and overlapping confidence intervals, these patterns cannot be considered evidence of differential effectiveness. Clinical implications The results have important implications for clinical practice and health systems, but implementation should proceed with caution. Integration of digital health communication tools, particularly mobile apps and web platforms, into preventive care pathways may facilitate screening uptake and healthier behaviours such as physical activity (59, 60). These tools may also support scalable patient education and engagement in resource-poor settings (61–63). AI-enabled tools may provide opportunities for personalized health messaging and adaptive decision support (64–66), but this review identified too little direct evidence to draw firm conclusions about their added effect relative to conventional digital tools (67). Similar caution applies to telehealth/video and social media modalities, which were underrepresented. Although findings across underserved and low socioeconomic status populations suggest potential to reduce disparities (68), digital interventions could also widen inequities if access, usability, language, and digital literacy barriers are not addressed. These tools should therefore be regarded as adjuncts for education and engagement rather than alternatives to clinical care, pending more robust evidence of sustained clinical benefit (69, 70). Strength and limitations Strengths of this review include a comprehensive search strategy across multiple databases, registration and reporting in line with PRISMA and PROSPERO, duplicate screening and risk-of-bias assessment, and quantitative synthesis using random-effects models. Cochrane methods for risk of bias assessment and GRADE evaluation were applied, strengthening methodological rigor. Several limitations should be noted. First, heterogeneity was substantial and arose from differences in intervention modality, intensity, comparator type, target population, follow-up duration, and outcome measurement tools; therefore, pooled estimates should be interpreted as broad summary signals rather than precise estimates of a uniform intervention effect. Second, several pooled analyses included only a small number of studies, especially for behavioural outcomes and subgroup analyses, limiting power and making heterogeneity, publication-bias testing, and comparative subgroup interpretation unreliable. Third, some interventions contained overlapping features, such as AI embedded within mobile or web-based delivery, which limits attribution of effects to any single component even though a dominant-modality rule was used. Fourth, social media, telehealth/video, and AI-enabled modalities were underrepresented, so findings for these approaches remain preliminary. Fifth, several included studies had moderate-to-high risk of bias, lack of participant blinding was unavoidable, and self-reported outcomes were vulnerable to performance, detection, and social-desirability bias. Finally, the review was restricted to English-language, peer-reviewed publications, and grey literature, conference abstracts, dissertations, preprints, and unpublished studies were not systematically searched; publication and language bias therefore cannot be excluded. Additionally, DHL was rarely measured directly, so conclusions about true digital health literacy remain limited. Future directions Future research should prioritize standardized measurement of digital health literacy using validated tools, such as eHEALS (71) or the Digital Health Literacy Instrument (DHLI) (72), and should clearly distinguish digital literacy, disease-specific knowledge, behaviour change, empowerment, and clinical endpoints. Larger, adequately powered randomized trials are needed to evaluate AI-enabled interventions, with explicit reporting of what AI component was used, how it influenced personalization or decision support, and whether it adds benefit beyond conventional digital tools. Targeted evaluations are also needed for underrepresented modalities such as social media and telehealth/video delivery. Future studies should predefine core outcomes, use objective behavioural and clinical measures where possible, include longer follow-up, and report implementation context to improve comparability. Equity-focused design should address barriers among populations with low literacy or limited digital access through usability testing, language adaptation, accessibility standards, and culturally tailored content. Implementation-science approaches are also needed to examine integration into routine care, including provider training, workflow adaptation, governance, privacy, and cost-effectiveness. Conclusion This systematic review and meta-analysis suggests that digital health communication interventions may improve patient knowledge and selected behavioural outcomes, but the evidence remains cautious rather than definitive. Continuous knowledge/literacy outcomes showed a small, statistically non-significant effect and substantial heterogeneity, while significant behavioural findings were based on only a small number of studies. Evidence for AI-enabled, telehealth/video, and social-media interventions is especially limited, and clinical and empowerment outcomes remain too heterogeneous for firm conclusions. Current evidence supports the potential role of digital health communication tools as adjuncts for patient education and engagement, not as established stand-alone solutions. Further large-scale, methodologically robust trials using standardized outcome measures and direct digital health literacy assessment are required before firm conclusions about effectiveness can be drawn.